Prescription drugs and self-care products

Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products.

Our product portfolio includes:

  • Proprietary drugs developed by Orion itself
  • Substitutable generic drugs
  • Patented drugs licensed from other pharmaceutical companies
  • Self-care products such as non-prescription medicines, basic ointments and vitamins

Our own proprietary drugs

Human pharmaceuticals developed by Orion:

Drug name

Active pharmaceutical ingredient

Indication

Launched

Nubeqa®

darolutamide

prostate cancer

2019*

dexdor®

dexmedetomidine

intensive care sedative

2011

Stalevo®

levodopa, carbidopa, entacapone

Parkinson’s disease

2003

Simdax®

levosimendan

acute decompensated heart failure

2000

Precedex®

dexmedetomidine

intensive care sedative

1999

Comtess®/Comtan®

entacapone

Parkinson’s disease

1998

Fareston®

toremifene

breast cancer

1988

*) The U.S. Food and Drug Administration (FDA) has granted approval to darolutamide in July 2019. It is currently not approved by the European Medicines Agency or any other health authority outside the U.S.

 

 

 

 

Orion’s discoveries also include the Easyhaler® metered-dose dry powder inhaler for treatment of asthma and chronic obstructive pulmonary disease. The medicines used in Easyhaler devices are generic. The Easyhaler product family includes:

Drug name

Active pharmaceutical ingredient

Indication

Launched

Salmeterol/fluticasone Easyhaler®

salmeterol, fluticasone

asthma and chronic obstructive pulmonary disease

2018

Budesonide/formoterol Easyhaler®

budesonide, formoterol

asthma and chronic obstructive pulmonary disease

2014

Formoterol Easyhaler®

formoterol

asthma and chronic obstructive pulmonary disease

2004

Budesonide Easyhaler®

budesonide

asthma and chronic obstructive pulmonary disease

2002

Beclomet Easyhaler®

beclomethasone

asthma and chronic obstructive pulmonary disease

1994

Buventol Easyhaler®

salbutamol

asthma and chronic obstructive pulmonary disease

1993

Orion’s own proprietary products also include animal health products. More information on these products can be found here.